RLAY logo

Relay Therapeutics (RLAY) Cash And Cash Equivalents

Annual Cash & Cash Equivalents

$124.29 M
-$19.45 M-13.53%

December 31, 2024


Summary


Performance

RLAY Cash And Cash Equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherRLAYbalance sheetmetrics:

Quarterly Cash And Cash Equivalents

$124.29 M
-$28.07 M-18.42%

December 31, 2024


Summary


Performance

RLAY Quarterly Cash And Cash Equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherRLAYbalance sheetmetrics:

Cash And Cash Equivalents Formula

Cash & Cash Equivalents = Cash + Short-Term Investments

RLAY Cash And Cash Equivalents Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-13.5%-7.3%
3 y3 years-55.6%-55.6%
5 y5 years+196.3%+196.3%

RLAY Cash And Cash Equivalents Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-55.6%at low-65.0%+15.4%
5 y5-year-72.2%+196.3%-77.8%+196.3%
alltimeall time-72.2%+196.3%-77.8%+196.3%

Relay Therapeutics Cash And Cash Equivalents History

DateAnnualQuarterly
Dec 2024
$124.29 M(-13.5%)
$124.29 M(-18.4%)
Sep 2024
-
$152.36 M(+13.6%)
Jun 2024
-
$134.13 M(-12.3%)
Mar 2024
-
$152.87 M(+6.4%)
Dec 2023
$143.74 M(-5.3%)
$143.74 M(-5.0%)
Sep 2023
-
$151.33 M(+3.7%)
Jun 2023
-
$145.90 M(-9.5%)
Mar 2023
-
$161.28 M(+6.2%)
Dec 2022
$151.79 M
$151.79 M(-57.2%)
Sep 2022
-
$354.64 M(+229.2%)
Jun 2022
-
$107.74 M(-9.8%)
DateAnnualQuarterly
Mar 2022
-
$119.44 M(-57.4%)
Dec 2021
$280.12 M(-37.4%)
$280.12 M(+22.6%)
Sep 2021
-
$228.56 M(-12.1%)
Jun 2021
-
$260.07 M(-1.0%)
Mar 2021
-
$262.72 M(-41.3%)
Dec 2020
$447.65 M(+967.0%)
$447.65 M(-20.0%)
Sep 2020
-
$559.28 M(+308.1%)
Jun 2020
-
$137.05 M(+94.8%)
Mar 2020
-
$70.34 M(+67.7%)
Dec 2019
$41.95 M(-90.0%)
$41.95 M
Dec 2018
$421.50 M
-

FAQ

  • What is Relay Therapeutics annual cash & cash equivalents?
  • What is the all time high annual cash & cash equivalents for Relay Therapeutics?
  • What is Relay Therapeutics annual cash & cash equivalents year-on-year change?
  • What is Relay Therapeutics quarterly cash and cash equivalents?
  • What is the all time high quarterly cash and cash equivalents for Relay Therapeutics?
  • What is Relay Therapeutics quarterly cash and cash equivalents year-on-year change?

What is Relay Therapeutics annual cash & cash equivalents?

The current annual cash & cash equivalents of RLAY is $124.29 M

What is the all time high annual cash & cash equivalents for Relay Therapeutics?

Relay Therapeutics all-time high annual cash & cash equivalents is $447.65 M

What is Relay Therapeutics annual cash & cash equivalents year-on-year change?

Over the past year, RLAY annual cash & cash equivalents has changed by -$19.45 M (-13.53%)

What is Relay Therapeutics quarterly cash and cash equivalents?

The current quarterly cash and cash equivalents of RLAY is $124.29 M

What is the all time high quarterly cash and cash equivalents for Relay Therapeutics?

Relay Therapeutics all-time high quarterly cash and cash equivalents is $559.28 M

What is Relay Therapeutics quarterly cash and cash equivalents year-on-year change?

Over the past year, RLAY quarterly cash and cash equivalents has changed by -$9.84 M (-7.33%)